TABLE 6.
Detection Rate (%) and 95% CIs (%) for 68Ga-DOTATATE, 18F-FDG, 18F-FDOPA, 18F-FDA PET/CT, and CT/MRI Based on Lesion Location
| Detection rate | 68Ga-DOTATATE | 18F-FDG | 18F-FDOPA | 18F-FDA | CT/MRI |
| All compartments | 35.3 (25.0–47.2) | 42.3 (29.9–55.8) | 98.7 (92.7–99.8) | 98.3 (90.9–99.7) | 60.3 (48.8–70.7) |
| Neck | 100 (20.7–100) | 0.0 (0.0–79.4) | 100 (20.7–100) | 100 (20.7–100) | 0.0 (0.0–79.4) |
| Adrenal R | 0.0 (0.0–79.4) | 0.0 (0.0–79.4) | 100 (20.7–100) | 100 (20.7–100) | 0.0 (0.0–79.4) |
| Adrenal L | 50 (9.5–90.6) | 0.0 (0.0–65.6) | 100 (34.2–100) | 100 (34.2–100) | 100 (34.2–100) |
| Abdomen | 41.3 (28.3–55.6) | 46.8 (33.3–60.8) | 100 (93.1–100) | 100 (90.6–100) | 63.5 (49.9–75.2) |
| Liver | 25.0 (8.9–53.2) | 0.0 (0.0–79.4) | 91.7 (64.6–98.5) | 91.7 (64.6–98.5) | 41.7 (19.3–68.1) |
| Bone | 0.0 (0.0–39.1) | — | 100 (61.0–100) | 100 (61.0–100) | 50.0 (18.7–81.2) |